Puentes de Salud: Bridging Mental Health Gaps for Santa Cruz Seniors Read more about Puentes de Salud: Bridging Mental Health Gaps for Santa Cruz Seniors
Arizona Health Professionals for Climate Action (AZHPCA) Climate Health Grant 2024 Call for Proposals Read more about Arizona Health Professionals for Climate Action (AZHPCA) Climate Health Grant 2024 Call for Proposals
2023 Yuma County Community Health Improvement Plan (CHIP) Read more about 2023 Yuma County Community Health Improvement Plan (CHIP)
Inflammatory Bowel Disease (IBD) West Case Conference Read more about Inflammatory Bowel Disease (IBD) West Case Conference
Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation ? Redo Ablation Procedures: A Pilot Study Read more about Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation ? Redo Ablation Procedures: A Pilot Study
Ravulizumab To Protect Patients with Chronic Kidney Disease (CKD) From Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized Read more about Ravulizumab To Protect Patients with Chronic Kidney Disease (CKD) From Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized
MAGNITUDE: A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis Read more about MAGNITUDE: A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis
Lupus Nexus Landmark Study: A Prospective Registry and Biorepository Read more about Lupus Nexus Landmark Study: A Prospective Registry and Biorepository
EIK1003-001 (IMP1734-101): A First-in-Human, Phase 1/2, Open-Label, Multicenter, Dose-Escalation, Dose-Optimization, and Dose-Expansion Study To Evaluate the Safety, Tolerability, Pharmacokinetics, Ph Read more about EIK1003-001 (IMP1734-101): A First-in-Human, Phase 1/2, Open-Label, Multicenter, Dose-Escalation, Dose-Optimization, and Dose-Expansion Study To Evaluate the Safety, Tolerability, Pharmacokinetics, Ph
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eos Read more about A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eos
